A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection

Hepatitis B Virus Infection Clinical Trial

Official title:
A Randomized, Placebo-controlled,Observer-blinded Study, to Evaluate Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of RO7239958 in Healthy Volunteers and Patients With Chronic Hepatitis B Virus Infection

Status Terminated

Clinical Trial Summary

This study is designed to assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single and multiple ascending doses in healthy volunteers (HV) and participants diagnosed with chronic hepatitis B (CHB).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03762681
Study type	Interventional
Source	Hoffmann-La Roche
Contact
Status	Terminated
Phase	Phase 1
Start date	December 14, 2018
Completion date	April 6, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05392387` - Treatment and Prognosis of Patients With Chronic HBV Infection
Recruiting	`NCT06023056` - Hepatitis B Vaccination After Neonatal Surgery
Recruiting	`NCT05051098` - A Non-interventional Registry for Patients With Hepatitis B Virus Infection
Recruiting	`NCT03864263` - Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents
Completed	`NCT02798549` - HBV Virions Bound Proteins	N/A
Recruiting	`NCT03695029` - Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus	Phase 4
Completed	`NCT00440297` - Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)	Phase 3